{"id":790375,"date":"2024-11-25T08:15:54","date_gmt":"2024-11-25T13:15:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/"},"modified":"2024-11-25T08:15:54","modified_gmt":"2024-11-25T13:15:54","slug":"cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/","title":{"rendered":"Cue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference"},"content":{"rendered":"
\n

BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) — Cue Biopharma, Inc.<\/a>\u00a0(Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, announced today that it will take part in an unplugged fireside discussion at the Piper Sandler 36th Annual Healthcare Conference being held in New York, NY, Dec 3-5, 2024.<\/p>\n

During the fireside discussion,\u00a0Cue Biopharma\u00a0will provide an overview highlighting recent clinical and preclinical program updates as well as strategic business and partnering model objectives.<\/p>\n

\n Presentation Details<\/strong>
\n
\n Date and Time: <\/strong>Wednesday, December 4, 2024, from 9 a.m. EST \u2013 9:25 a.m. EST
Webcast Link:<\/strong>https:\/\/event.webcasts.com\/starthere.jsp?ei=1697351&tp_key=a82c532edc<\/a>
Presenter: <\/strong>Daniel Passeri,\u00a0M.Sc., J.D., chief executive officer,\u00a0Cue Biopharma<\/p>\n

\n A live and archived webcast of the fireside discussion will be available on the Events page in the Investors and Media section of the Company\u2019s website at\u00a0<\/em>
\n
\n www.cuebiopharma.com<\/em>
\n <\/a>
\n . The webcast will be archived for 30 days.<\/em>\n <\/p>\n

\n About\u00a0Cue Biopharma<\/strong>
\n
Cue Biopharma, a clinical-stage biopharmaceutical company, is developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient\u2019s body. The company\u2019s proprietary platform, Immuno-STAT\u2122 (Selective Targeting and Alteration of T cells)<\/em>, and biologics are designed to harness the curative potential of the body\u2019s intrinsic immune system through the selective modulation of disease-specific T cells without the adverse effects of broad systemic immune modulation.<\/p>\n

Headquartered in\u00a0Boston, Massachusetts, we are led by an experienced management team and independent Board of Directors with deep expertise in immunology and immuno-oncology as well as the design and clinical development of protein biologics.<\/p>\n

For more information please visit\u00a0www.cuebiopharma.com<\/a>\u00a0and follow us on\u00a0X<\/a>\u00a0and\u00a0LinkedIn<\/a>.<\/p>\n

\n Investor Contact <\/strong>
\n
Marie Campinell\u00a0
Senior Director, Corporate Communications
Cue Biopharma, Inc.
mcampinell@cuebio.com<\/a><\/p>\n

\n Media Contact<\/strong>
\n
Jonathan Pappas
LifeSci Communications
jpappas@lifescicomms.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) — Cue Biopharma, Inc.\u00a0(Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, announced today that it will take part in an unplugged fireside discussion at the Piper Sandler 36th Annual Healthcare Conference being held in New York, NY, Dec 3-5, 2024. During the fireside discussion,\u00a0Cue Biopharma\u00a0will provide an overview highlighting recent clinical and preclinical program updates as well as strategic business and partnering model objectives. Presentation Details Date and Time: Wednesday, December 4, 2024, from 9 a.m. EST \u2013 9:25 a.m. ESTWebcast Link:https:\/\/event.webcasts.com\/starthere.jsp?ei=1697351&tp_key=a82c532edcPresenter: Daniel Passeri,\u00a0M.Sc., J.D., chief executive officer,\u00a0Cue Biopharma A live and archived … <\/p>\n

Continue reading “Cue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-790375","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) — Cue Biopharma, Inc.\u00a0(Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, announced today that it will take part in an unplugged fireside discussion at the Piper Sandler 36th Annual Healthcare Conference being held in New York, NY, Dec 3-5, 2024. During the fireside discussion,\u00a0Cue Biopharma\u00a0will provide an overview highlighting recent clinical and preclinical program updates as well as strategic business and partnering model objectives. Presentation Details Date and Time: Wednesday, December 4, 2024, from 9 a.m. EST \u2013 9:25 a.m. ESTWebcast Link:https:\/\/event.webcasts.com\/starthere.jsp?ei=1697351&tp_key=a82c532edcPresenter: Daniel Passeri,\u00a0M.Sc., J.D., chief executive officer,\u00a0Cue Biopharma A live and archived … Continue reading "Cue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-25T13:15:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI3ODcyOCM2NTk3Mjk0IzIwOTI2OTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference\",\"datePublished\":\"2024-11-25T13:15:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\\\/\"},\"wordCount\":333,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI3ODcyOCM2NTk3Mjk0IzIwOTI2OTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\\\/\",\"name\":\"Cue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI3ODcyOCM2NTk3Mjk0IzIwOTI2OTI=\",\"datePublished\":\"2024-11-25T13:15:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI3ODcyOCM2NTk3Mjk0IzIwOTI2OTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI3ODcyOCM2NTk3Mjk0IzIwOTI2OTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Cue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference - Market Newsdesk","og_description":"BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) — Cue Biopharma, Inc.\u00a0(Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, announced today that it will take part in an unplugged fireside discussion at the Piper Sandler 36th Annual Healthcare Conference being held in New York, NY, Dec 3-5, 2024. During the fireside discussion,\u00a0Cue Biopharma\u00a0will provide an overview highlighting recent clinical and preclinical program updates as well as strategic business and partnering model objectives. Presentation Details Date and Time: Wednesday, December 4, 2024, from 9 a.m. EST \u2013 9:25 a.m. ESTWebcast Link:https:\/\/event.webcasts.com\/starthere.jsp?ei=1697351&tp_key=a82c532edcPresenter: Daniel Passeri,\u00a0M.Sc., J.D., chief executive officer,\u00a0Cue Biopharma A live and archived … Continue reading \"Cue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2024-11-25T13:15:54+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI3ODcyOCM2NTk3Mjk0IzIwOTI2OTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference","datePublished":"2024-11-25T13:15:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/"},"wordCount":333,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI3ODcyOCM2NTk3Mjk0IzIwOTI2OTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/","name":"Cue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI3ODcyOCM2NTk3Mjk0IzIwOTI2OTI=","datePublished":"2024-11-25T13:15:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI3ODcyOCM2NTk3Mjk0IzIwOTI2OTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI3ODcyOCM2NTk3Mjk0IzIwOTI2OTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-participate-in-fireside-discussion-at-the-piper-sandler-36th-annual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cue Biopharma\u00a0to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/790375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=790375"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/790375\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=790375"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=790375"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=790375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}